Mirae Asset Global Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-70,191
Closed -$2.76M 2680
2023
Q2
$2.76M Sell
70,191
-4,741
-6% -$167K 0.01% 1063
2023
Q1
$1.82M Buy
74,932
+14,262
+24% +$312K ﹤0.01% 1255
2022
Q4
$1.3M Buy
60,670
+7,952
+15% +$170K ﹤0.01% 1354
2022
Q3
$946K Buy
52,718
+16,925
+47% +$222K ﹤0.01% 1511
2022
Q2
$345K Buy
+35,793
New +$449K ﹤0.01% 1919

Mirae Asset Global Investments's ISEE Position: Q3 2023 in Review

Mirae Asset Global Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 70,191 shares — an estimated $2.76M sold.

Mirae Asset Global Investments first reported a position in ISEE in Q2 2022 and held it in 5 quarters. The position peaked at $2.76M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Mirae Asset Global Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 70,191 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.76M.
  • Mirae Asset Global Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's IVERIC bio, Inc. Common Stock position peaked at $2.76M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Mirae Asset Global Investments's 13F filing for Q3 2023, filed 26 Oct 2023.